Source: FDA, document on fileFDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it.
To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3010199915.
AstraZeneca Pharmaceuticals, LP
Coppell, Texas, United States
Issue DateApril 19, 2017
FEI Number3010199915
CountryUnited States
Status
No Warning Letter
Product Type
Drugs
Establishment Type
Active Pharmaceutical Ingredient Manufacturer
AstraZeneca Pharmaceuticals, LP FDA Form 483, Coppell, Texas, April 19, 2017
